teaser
Access to innovative medicines for all European patients can only be possible if clear framework conditions for pricing and reimbursement are set at European Union level, according to Mr Rolf Schwanitz, State Secretary at Germany
Published on 2 July 2007
EU new-drug cooperation urged
Most read
1
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
